Millipore Sigma Vibrant Logo

EQCTMG93KPX23BK MILLIPLEX MAP Equine Cytokine/Chemokine Magnetic Bead Panel Premix Space Saver (Bulk) Packaging

The Equine Inflammation / Immunology Bead-Based Multiplex Cytokine Assay kit, using the Luminex xMAP technology, enables the simultaneous analysis of 23 cytokine and chemokine biomarkers in equine serum, plasma and cell culture samples.

View Products on Sigmaaldrich.com
EQCTMG93KPX23BK
96-well plate  96 well plate
Recuperando preço...
O preço não pôde ser recuperado
Quantidade mínima necessária para ser múltipla de
Maximum Quantity is
Após finalização do pedido Mais informações
Você salvou ()
 
—
Solicitar preço
—
Disponibilidade limitada Disponibilidade limitada
Insira quantidade 
Descontinuado
Quantidades limitadas disponíveis
Disponibilidade a ser confirmada
    Restante: será informado
      Restante: será informado
      Vai informar
      Contatar o serviço de atendimento ao cliente
      Contact Customer Service

       

      Contatar o serviço de atendimento ao cliente

      Panorama geral

      Replacement Information
      Description
      Catalogue NumberEQCTMG93KPX23BK
      Trade Name
      • MILLIPLEX
      DescriptionMILLIPLEX MAP Equine Cytokine/Chemokine Magnetic Bead Panel Premix Space Saver (Bulk) Packaging
      OverviewEMD Millipore’s MILLIPLEX® MAP Equine Cytokine Magnetic Bead Premix Panel is a 23-plex kit to be used for the simultaneous quantification of any or all of the following analytes in serum, plasma or culture supernatant samples: Eotaxin/CCL11, FGF-2. Fractalkine/CS3CL1, G-CSF, GM-CSF, GRO, IFN, IL-1α, IL-1β, IL-2, IL-4, IL-5, IL-6, IL-8/CXCL8, IL-10, IL-12 (p70), IL-13, IL-17a, IL-18, IP-10, MCP-1, RANTES/CCL5 and TNFα.

      MILLIPLEX® MAP offers the broadest selection of analytes across a wide range of disease states and species. Once the analytes of interest have been identified, you can rely on the quality that we build into each kit to produce results you can trust. In addition to the assay characteristics listed in the protocol, other performance criteria evaluated during the validation process include: cross-reactivity, dilution linearity, kit stability, and sample behavior (e.g. detectability and stability). Each panel and kit meets stringent manufacturing criteria to ensure batch-to-batch reproducibility.

      Each MILLIPLEX® MAP panel and kit includes:
      • Quality controls (QCs) provided to qualify assay performance

      • Comparison of standard (calibrator) and QC lots to a reference lot to ensure lot-to-lot consistency

      • Optimized serum matrix to mimic native analyte environment

      • Detection antibody cocktails designed to yield consistent analyte profiles within panel


      EMD Millipore’s MILLIPLEX® MAP Equine Cytokine Magnetic Bead Panel is part of the most versatile system available for cytokine research. From our single to multiplex biomarker solutions, we partner with you to design, develop, analytically validate and build the most comprehensive library available for protein detection and quantitation.
      Background InformationInflammation and immune cell response are key to maintaining homeostasis. The more we understand the mechanisms of disease, the more we discover the role that inflammation plays in the etiology of disease. This is a true for horses as it is for humans. Both experience immunological diseases, such as infectious disease, osteoarthritis and respiratory disease, as well as neurologic, metabolic and cardiovascular disease and even cancer. However, until now the ability to measure levels of cytokines and chemokine in horses has been limited primarily to ELISAs. However, researchers will now the ability to measure multiple inflammation biomarkers simultaneously using EMD Millipore’s MILLIPLEX ® MAP Equine Cytokine/Chemokine Panel, based on the Luminex xMAP® technology.
      References
      Product Information
      Detection methodLuminex xMAP
      ConfigurationPremixed
      Precision, %
      • Inter-assay: <20
      • Intra-assay: <10
      Panel TypeMAGNETIC Cytokines/Chemokines
      Quality LevelMQ200
      Applications
      ApplicationThe Equine Inflammation / Immunology Bead-Based Multiplex Cytokine Assay kit, using the Luminex xMAP technology, enables the simultaneous analysis of 23 cytokine and chemokine biomarkers in equine serum, plasma and cell culture samples.
      Key Applications
      • Multiplexing
      Application Notes• This is an overnight (16-18 hours at 2-8 °C) or two-hour (20-25°C) incubation assay; although an overnight incubation is recommended.
      • A maximum of 25 µL per well of neat serum or plasma can be used. Tissue culture supernatant may require a dilution with an appropriate control medium prior to assay.
      • This kit may be used for the analysis of all of the Equine Cytokine/Chemokine Panel analytes in serum, plasma or tissue/cell/tumor culture supernatant.
      Biological Information
      SpecificityCross-reactivity between the antibodies and any of the other analytes in this panel is non-detectable or negligible.
      Species Reactivity
      • Horse
      Analytes Available
      • Eotaxin/CCL11
      • FGF-2
      • Fractalkine/CX3CL1
      • G-CSF
      • GM-CSF
      • GRO/KC
      • IFN-γ
      • IL-1α
      • IL-1β
      • IL-2
      • IL-4
      • IL-5
      • IL-6
      • IL-8
      • IL-10
      • IL-12 (p70)
      • IL-13
      • IL-17A
      • IL-18
      • IP-10
      • MCP-1
      • RANTES
      • TNF-α
      Cross ReactivityCross-reactivity between the antibodies and any of the other analytes in this panel is non-detectable or negligible.
      Accuracy
      • Eotaxin/CCL11: 93%
      • FGF-2: 78%
      • Fractalkine/CS3CL1: 91%
      • G-CSF: 82%
      • GM-CSF: 92%
      • GRO: 97%
      • IFNγ: 83%
      • IL-1α: 89%
      • IL-1β: 88%
      • IL-2: 90%
      • IL-4: 91%
      • IL-5: 92%
      • IL-6: 76%
      • IL-8/CXCL8: 89%
      • IL-10: 86%
      • IL-12 (p70): 83%
      • IL-13: 85%
      • IL-17a: 74%
      • IL-18: 94%
      • IP-10: 86%
      • MCP-1: 90%
      • RANTES/CCL5: 88%
      • TNFα: 87%
      Physicochemical Information
      Sensitivity
      • Eotaxin/CCL11: 8.3 pg/mL
      • FGF-2: 16.3 pg/mL
      • Fractalkine/CS3CL1: 457 pg/mL
      • G-CSF: 340 pg/mL
      • GM-CSF: 3.94 pg/mL
      • GRO: 7.8 pg/mL
      • IFNγ: 165 pg/mL
      • IL-1α: 39.1 pg/mL
      • IL-1β: 29.3 pg/mL
      • IL-2: 13.5 pg/mL
      • IL-4: 355 pg/mL
      • IL-5: 10.6 pg/mL
      • IL-6: 1.4 pg/mL
      • IL-8/CXCL8: 74.3 pg/mL
      • IL-10: 62.5 pg/mL
      • IL-12 (p70): 49.2 pg/mL
      • IL-13: 39 – 130 pg/mL
      • IL-17A: 15.4 pg/mL
      • IL-18: 25.3 pg/mL
      • IP-10: 16.7 pg/mL
      • MCP-1: 399 ng/mL
      • RANTES/CCL5: 3.9 pg/mL
      • TNFα: 5.2 pg/mL
      Standard Curve Range
      • Eotaxin/CCL11: 7 – 7,000 pg/mL
      • FGF-2: 24 – 25,000 pg/mL
      • Fractalkine/CS3CL1: 586 – 600,000 pg/mL
      • G-CSF: 78 – 80,000 pg/mL
      • GM-CSF: 5 – 5,000 pg/mL
      • GRO: 6 – 6,000 pg/mL
      • IFNγ: 488 – 500,000 pg/mL
      • IL-1α: 59 – 60,000 pg/mL
      • IL-1β: 29 – 30,000 pg/mL
      • IL-2: 15 – 15,000 pg/mL
      • IL-4: 293 – 300,000 pg/mL
      • IL-5: 15 – 15,000 pg/mL
      • IL-6: 15 – 15,000 pg/mL
      • IL-8/CXCL8: 59 – 60,000 pg/mL
      • IL-10: 49 – 50,000 pg/mL
      • IL-12 (p70): 39- 40,000 pg/mL
      • IL-13: 39 – 40,000 pg/mL
      • IL-17A: 15 – 15,000 pg/mL
      • IL-18: 34 – 35,000 pg/mL
      • IP-10: 15 – 15,000 pg/mL
      • MCP-1: 342 – 350,000 ng/mL
      • RANTES/CCL5: 5 – 5,000 pg/mL
      • TNFα: 4 - 4,000 pg/mL
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Usage Statement
      • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
      Storage and Shipping Information
      Storage ConditionsRecommended storage for kit components is 2 - 8°C.
      Packaging Information
      Material Size96-well plate
      Material Package96 well plate
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Número de catálogo GTIN
      EQCTMG93KPX23BK 04055977350135

      Documentation

      Protocols

      Title
      Protocol- EQCYTMAG-93K|EQCYTMG-93KPX23|EQCTMG93KPX23BK
      Protocol-MILLIPLEX® Equine Cytokine/Chemokine Magnetic Bead Panel

      MILLIPLEX MAP Equine Cytokine/Chemokine Magnetic Bead Panel Premix Space Saver (Bulk) Packaging MSDS

      Título

      Ficha de Segurança de Produtos (MSDS) 

      Informações técnicas

      Título
      96 well Template 2 Up
      96 well Template Single
      Quality Control Range Sheet- CYT-107 and CYT-207
      Quality Control Range Sheet- CYT-109 and CYT-209
      Quality Control Ranges: Milliplex® MAP Equine Cytokine/Chemokine Magnetic Bead Panel

      Manuais do usuário

      Título
      User Guide-EQCYTMAG-93K|EQCYTMG-93PX23|EQCTMG93KPX23BK

      Produtos e aplicações relacionadas

      Related Products

      Número de catálogo Descrição  
      EQCYTMAG-93K MILLIPLEX MAP Equine Cytokine/Chemokine Magnetic Bead Panel - Immunology Multiplex Assay Preço e disponibilidade

      Produtos relacionados por: Brand Facete

      MILLIPLEX®